Filing Flows › Biotricity (BTCY) › How it makes money
How Biotricity (BTCY) makes money
Biotricity (BTCY) made $4.3M of revenue in the first quarter fiscal 2027 (Q1 FY27), +10% from a year earlier. Technology Fees brought in $4.2M (97%); Device Sales brought in $111K (3%).
Drawing the Sankey…
Revenue by segment, Q1 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Technology Fees | $4.2M | 97.4% | +6% | +24% |
| Device Sales | $111K | 2.6% | -66% | -78% |
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $4.3M | 100.0% |
| Operating cash flow | $507K | 11.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $4.3M | +10% |
| Q4 FY26 | $4.3M | +15% |
| Q3 FY26 | $4.0M | +10% |
| Q2 FY26 | $3.9M | +19% |
| Q1 FY26 | $3.9M | +21% |
| Q4 FY25 | $3.7M | +16% |
| Q3 FY25 | $3.6M | +22% |
From Biotricity's 10-Q filed Aug 19, 2026 (on EDGAR).
Questions
How does Biotricity make money?
Biotricity (BTCY) made $4.3M of revenue in the first quarter fiscal 2027 (Q1 FY27), +10% from a year earlier. Technology Fees brought in $4.2M (97%); Device Sales brought in $111K (3%).
What is Biotricity's biggest business?
Technology Fees: $4.2M in the first quarter fiscal 2027, 97% of revenue, +24% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.